Inventor · disambiguated record
Olga Rodny
Also filed as: RODNY OLGA
27 granted patents·11 pending applications·270 citations·filing 2009–2024
97Inventor score
Files withREMPEX PHARMACEUTICALS INC9HORIZON ORPHAN LLC8QPEX BIOPHARMA INC6RAPTOR PHARMACEUTICALS INC3GLINKA TOMASZ2
Top patents by PatentIndex Score
38 records- 0197US11180512B2Boronic acid derivatives and therapeutic uses thereofQPEX BIOPHARMA INC·Filed 2020·Granted Nov 23, 2021·4 cites·20 claims
- 0297US9694025B2Cyclic boronic acid ester derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2016·Granted Jul 4, 2017·21 cites·14 claims
- 0396US11999759B2Boronic acid derivatives and therapeutic uses thereofQPEX BIOPHARMA INC·Filed 2021·Granted Jun 4, 2024·2 cites·21 claims
- 0496US10004758B2Cyclic boronic acid ester derivatives and methods of making the sameREMPEX PHARMACEUTICALS INC·Filed 2017·Granted Jun 26, 2018·18 cites·30 claims
- 0596US9296763B2Cyclic boronic acid ester derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2013·Granted Mar 29, 2016·27 cites·24 claims
- 0696US8680136B2Cyclic boronic acid ester derivatives and therapeutic uses thereofHIRST GAVIN·Filed 2011·Granted Mar 25, 2014·69 cites·27 claims
- 0795US10570159B2Boronic acid derivatives and therapeutic uses thereofQPEX BIOPHARMA INC·Filed 2019·Granted Feb 25, 2020·6 cites·26 claims
- 0895US9963467B2Boronic acid derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2015·Granted May 8, 2018·14 cites·31 claims
- 0994US8357696B2Aerosolized fluoroquinolones and uses thereofMPEX PHARMACEUTICALS INC·Filed 2010·Granted Jan 22, 2013·20 cites·43 claims
- 1093US10639318B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesREMPEX PHARMACEUTICALS INC·Filed 2018·Granted May 5, 2020·3 cites·21 claims
- 1193US10206937B2Boronic acid derivatives and therapeutic uses thereofQPEX BIOPHARMA INC·Filed 2015·Granted Feb 19, 2019·17 cites·43 claims
- 1293US10183034B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesREMPEX PHARMACEUTICALS INC·Filed 2018·Granted Jan 22, 2019·7 cites·29 claims
- 1393US10172874B2Pharmaceutical compositions comprising cyclic boronic acid ester derivativesREMPEX PHARMACEUTICALS INC·Filed 2018·Granted Jan 8, 2019·7 cites·24 claims
- 1492US2025064838A1Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesMELINTA SUBSIDIARY CORP·Filed 2024·Application pending·0 cites
- 1591US10294249B2Boronic acid derivatives and therapeutic uses thereofQPEX BIOPHARMA INC·Filed 2017·Granted May 21, 2019·8 cites·38 claims
- 1691US8815838B2Aerosol fluoroquinolone formulations for improved pharmacokineticsGRIFFITH DAVID C·Filed 2009·Granted Aug 26, 2014·18 cites·80 claims
- 1790US9717738B2Aerosol fluoroquinolone formulations for improved pharmacokineticsRAPTOR PHARMACEUTICALS INC·Filed 2016·Granted Aug 1, 2017·6 cites·29 claims
- 1888US9326936B2Aerosol fluoroquinolone formulations for improved pharmacokineticsRAPTOR PHARMACEUTICALS INC·Filed 2014·Granted May 3, 2016·7 cites·17 claims
- 1987US12509475B2Boronic acid derivatives and therapeutic uses thereofQPEX BIOPHARMA INC·Filed 2024·Granted Dec 30, 2025·0 cites·20 claims
- 2087US10987357B2Aerosolized fluoroquinolones and uses thereofHORIZON ORPHAN LLC·Filed 2019·Granted Apr 27, 2021·1 cites·13 claims
- 2184US10149854B2Aerosol fluoroquinolone formulations for improved pharmacokineticsHORIZON ORPHAN LLC·Filed 2017·Granted Dec 11, 2018·2 cites·20 claims
- 2284US8629139B2Topical use of Levofloxacin for reducing lung inflammationDUDLEY MICHAEL N·Filed 2009·Granted Jan 14, 2014·10 cites·47 claims
- 2382US10722519B2Aerosol fluoroquinolone formulations for improved pharmacokineticsHORIZON ORPHAN LLC·Filed 2018·Granted Jul 28, 2020·1 cites·10 claims
- 2476US10561675B2Cyclic boronic acid ester derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2013·Granted Feb 18, 2020·2 cites·14 claims
- 2572US2021121472A1Aerosol fluoroquinolone formulations for improved pharmacokineticsHORIZON ORPHAN LLC·Filed 2020·Application pending·0 cites
- 2670US2022080047A1Topical use of levofloxacin for reducing lung inflammationHORIZON ORPHAN LLC·Filed 2021·Application pending·0 cites
- 2767US11020481B2Topical use of levofloxacin for reducing lung inflammationHORIZON ORPHAN LLC·Filed 2017·Granted Jun 1, 2021·0 cites·5 claims
- 2861US2016279138A1Aerosolized fluoroquinolones and uses thereofRAPTOR PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2958US2014105985A1Topical use of levofloxacin for reducing lung inflammationMPEX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3056US2022047604A1Aerosolized fluoroquinolones and uses thereofHORIZON ORPHAN LLC·Filed 2021·Application pending·0 cites
- 3153US2021015811A1Methods of treating a pulmonary bacterial infection using fluoroquinolonesHORIZON ORPHAN LLC·Filed 2020·Application pending·0 cites
- 3251US2014128364A1Therapeutic uses of tigemonam and carumonamRempex Pharmaceuticals·Filed 2013·Application pending·0 cites
- 3350US2015119363A1Methods of treating bacterial infectionsRAMPEX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3449US8178490B2Polybasic bacterial efflux pump inhibitors and therapeutic uses thereofGLINKA TOMASZ·Filed 2009·Granted May 15, 2012·0 cites·15 claims
- 3545US2014275007A1Oxamazin antibioticsREMPEX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3638US8933018B2Boron containing polybasic bacterial efflux pump inhibitors and therapeutic uses thereofGLINKA TOMASZ·Filed 2012·Granted Jan 13, 2015·0 cites·29 claims
- 3738US8906868B2Aminoglycoside derivativesGLINKA TOMASZ W·Filed 2011·Granted Dec 9, 2014·0 cites·32 claims
- 3835US2012035166A1Methods of treating a pulmonary bacterial infection using fluoroquinolonesDUDLEY MIKE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Olga Rodny files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →